Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder
J Eat Disord. 2024 Jun 13;12(1):80. doi: 10.1186/s40337-024-01041-9. ABSTRACT BACKGROUND: Lisdexamfetamine dimesylate (LDX) has demonstrated safety and efficacy for treatment of Binge Eating Disorder (BED). …